FBXW7 and breast cancer: SRY-related HMG-box 4 (SOX4) binding to the FBXW7 promoter upregulates FBXW7 expression in ER + breast cancers, causing enhanced turnover of GATA-binding protein 3 (GATA3), and thus promoting tamoxifen tolerance [123].